NDC 50090-1006-01 - Glimepiride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-1006
- Requested NDC
- 50090-1006-01
- Package NDCs from labels
- 50090-1006-0, 50090-1006-3, 50090-1006-4, 50090-1006-1, 50090-1006-2, 50090-1006-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-06-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glimepiride - A-S Medication Solutions | A-S Medication Solutions | 2023-06-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-1006-0 | Glimepiride | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 50090-1006-1 | Glimepiride | 100 in 1 BOTTLE | TABLET | 100 | 3 | |
| 50090-1006-2 | Glimepiride | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 50090-1006-3 | Glimepiride | 90 in 1 BOTTLE | TABLET | 90 | 3 | |
| 50090-1006-4 | Glimepiride | 180 in 1 BOTTLE | TABLET | 180 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-1006 | GLIMEPIRIDE TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 5 package rows | 20230623_def20e38-01f7-4ead-beb6-3dc11062a342.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-1006-0 | EA - Each | 50090-1006 | 4726f8f7-6b3d-46db-8ca6-a2dc7f605bbd | 1 | 2023-05-05 |
| 50090-1006-1 | EA - Each | 50090-1006 | 11f2ceef-290a-4fe0-8159-f93d9811450b | 1 | 2023-05-05 |
| 50090-1006-2 | EA - Each | 50090-1006 | ae9ebe9b-c8ff-4938-8f71-4eb124757b16 | 1 | 2023-05-05 |
| 50090-1006-3 | EA - Each | 50090-1006 | 0057bd01-84f2-45e0-8f1d-0d171db7af6f | 1 | 2023-05-05 |
| 50090-1006-4 | EA - Each | 50090-1006 | 6811f6b5-c6d1-4edf-9199-accb2e980837 | 1 | 2023-05-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quality Choice Moisturizing Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Chain Drug Marketing Association, Inc. | 1fb81759-5931-59c8-e063-6294a90a2277 | 2025-12-30 | Warnings | FZ989GH94E |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | b6ce0eea-149d-4aed-a615-0b1c8f3f6a8e | 2025-12-30 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Northwind Health Company, LLC | 10a36c79-1b24-46b7-e063-6294a90a8dca | 2025-12-26 | Warnings, Adverse reactions | 199246 6KY687524K |
| pioglitazone and glimepiride | PIOGLITAZONE AND GLIMEPIRIDE | Prasco Laboratories | ea385b3d-cb4c-4550-97b0-93a86533f6dc | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 6KY687524K |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | FZ989GH94E |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | FZ989GH94E |
| Stye | POLYVINYL ALCOHOL AND POVIDONE | Medtech Products Inc. | 60c11d3d-df20-4d1c-b425-49a84fecea30 | 2025-10-23 | Warnings | FZ989GH94E |
| iVIZIA Dry Eye | POVIDONE | Thea Pharma Inc. | 1ef73cb1-da48-a713-e063-6294a90afa9d | 2025-10-20 | Warnings | FZ989GH94E |
| Glimepiride | GLIMEPIRIDE | Accord Healthcare Inc | 9b74fbac-9e04-4927-9981-1e3dace89c6d | 2025-10-17 | Warnings, Adverse reactions | 199247 199245 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 101cdc41-2131-4425-b550-6a0a60b5f4a4 | 2025-10-15 | Warnings, Adverse reactions | ANDA077091 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 657f1b51-2f82-44f6-a23d-97f4b34b3c45 | 2025-10-15 | Warnings, Adverse reactions | ANDA077091 199245 6KY687524K |
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | FZ989GH94E |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | 489dc098-0ac7-4f8e-b258-326229539c7c | 2025-08-15 | Warnings, Adverse reactions | 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | be7175ae-ba53-45b8-9554-e4f4ebf56883 | 2025-08-15 | Warnings, Adverse reactions | 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | BluePoint Laboratories | a01b0466-13f5-4c47-ae55-c5f1527d9414 | 2025-07-07 | Warnings, Adverse reactions | 199247 199245 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | d4513181-4558-4d9a-851b-acf7e3eda25a | 2025-06-16 | Warnings, Adverse reactions | 199245 6KY687524K |
| Glimepiride | GLIMEPIRIDE | ST. MARY'S MEDICAL PARK PHARMACY | 35ba31ef-2b90-61c6-e063-6394a90a59ee | 2025-05-22 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Micro Labs Limited | 60e9397e-83b9-489e-9683-6f87e458bbaa | 2025-05-12 | Warnings, Adverse reactions | 199247 199245 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | 49bf2d48-efa8-487b-b861-0124c3a4c951 | 2025-04-01 | Warnings, Adverse reactions | 199245 6KY687524K |
| Duetact | PIOGLITAZONE AND GLIMEPIRIDE | Takeda Pharmaceuticals America, Inc. | f8b0c917-3fdd-4a28-a47d-6225b8195458 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | 6KY687524K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.